ATE339429T1 - Neue cytotoxische verbindungen und deren verwendung - Google Patents

Neue cytotoxische verbindungen und deren verwendung

Info

Publication number
ATE339429T1
ATE339429T1 AT01945899T AT01945899T ATE339429T1 AT E339429 T1 ATE339429 T1 AT E339429T1 AT 01945899 T AT01945899 T AT 01945899T AT 01945899 T AT01945899 T AT 01945899T AT E339429 T1 ATE339429 T1 AT E339429T1
Authority
AT
Austria
Prior art keywords
cysteamine
phospho
aminoethanol
phosphate
linolenoyl
Prior art date
Application number
AT01945899T
Other languages
English (en)
Inventor
Oleg Strelchenok
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002629A external-priority patent/SE0002629D0/xx
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Application granted granted Critical
Publication of ATE339429T1 publication Critical patent/ATE339429T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C07F9/1651—Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT01945899T 2000-07-12 2001-07-05 Neue cytotoxische verbindungen und deren verwendung ATE339429T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21781000P 2000-07-12 2000-07-12
SE0002629A SE0002629D0 (sv) 2000-07-12 2000-07-12 Novel compounds and their use

Publications (1)

Publication Number Publication Date
ATE339429T1 true ATE339429T1 (de) 2006-10-15

Family

ID=26655180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945899T ATE339429T1 (de) 2000-07-12 2001-07-05 Neue cytotoxische verbindungen und deren verwendung

Country Status (7)

Country Link
US (1) US6699851B2 (de)
EP (1) EP1299400B1 (de)
AT (1) ATE339429T1 (de)
AU (1) AU2001268007A1 (de)
DE (1) DE60123058T2 (de)
ES (1) ES2272490T3 (de)
WO (1) WO2002004467A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG185754A1 (en) * 2010-06-08 2012-12-28 Mahesh Kandula Cysteamine derivatives and their use in the treatment of nash
WO2014045293A1 (en) * 2012-09-24 2014-03-27 Krisani Bioscience (P) Ltd. Fatty acid amides with a cysteamine or an acetylated cysteamine group and uses thereof
MX2021009328A (es) * 2019-02-21 2021-11-12 Univ Claude Bernard Lyon Vectores moleculares estructurados y usos de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) * 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
SE9900941D0 (sv) 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
HK1041889B (zh) * 1999-03-11 2005-03-18 阿登尼亚投资有限公司 治疗癌症的新化合物

Also Published As

Publication number Publication date
DE60123058T2 (de) 2007-04-05
US6699851B2 (en) 2004-03-02
AU2001268007A1 (en) 2002-01-21
EP1299400B1 (de) 2006-09-13
WO2002004467A1 (en) 2002-01-17
DE60123058D1 (de) 2006-10-26
US20030171338A1 (en) 2003-09-11
EP1299400A1 (de) 2003-04-09
ES2272490T3 (es) 2007-05-01

Similar Documents

Publication Publication Date Title
YU57599A (sh) Primena derivata fumarne kiseline
AU2003201693A1 (en) Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
DK0749432T3 (da) 9-deoxotaxan-forbindelser
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
IS2180B (is) Lyfjasamsetning sem inniheldur eikósapentaensýru og/eða steridónsýru
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
PL366435A1 (en) Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
CA2399039A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
BRPI0413259A (pt) composições antimicrobianas que incluem ácidos carboxìlicos e aminas alcoxiladas
ATE402607T1 (de) Delta-4-desaturase-gene und ihre verwendung
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
DK1135998T3 (da) Anvendelse af syntetiske triglycerider på basis af konjugeret linolsyre som antioxidant i levnedsmidler
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
FR2800608B1 (fr) Composition cosmetique contenant un ester d'acide gras hydroxyle
NZ513569A (en) Process for the preparation of (2R)-2-propyloctanoic acid
SE9900941D0 (sv) Novel retinoic acid derivatives and their use
CA2404480A1 (en) Compositions containing polycarbonate
CA2421990A1 (en) .beta.-thioamino acids
DE60123058D1 (de) Neue cytotoxische verbindungen und deren verwendung
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
TR200000444T2 (tr) 3-Aril-süksinamido-hidroksamik asitler, üretim yöntemleri ve bu maddeleri içeren farmasötik terkipler.
DE59808546D1 (de) Verwendung von fettsäureniedrigalkylestern in abbeizmitteln
ES2111297T3 (es) Nuevos esteres de acidos carboxilicos de 2-amino-7-(1,3-dihidroxi-2-propoximetil)purina, su preparacion asi como su empleo.
ES2157617T3 (es) Nuevos derivados de benzoxacindionas conjugados con principios activos.
HUP0202630A2 (hu) Meiózisra ható anyagokat tartalmazó készítmények

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1299400

Country of ref document: EP